Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Current status in therapeutic interventions of neonatal bone mineral metabolic disorders.

Chinoy A, Mughal MZ, Padidela R.

Semin Fetal Neonatal Med. 2019 Dec 14:101075. doi: 10.1016/j.siny.2019.101075. [Epub ahead of print]

PMID:
31879202
2.

Paradoxical Response of Parathyroid Hormone to Vitamin D-Calcium Supplementation in Indian Children.

Mandlik RM, Mughal ZM, Khadilkar AV, Ekbote VH, Kajale NA, Patwardhan VG, Khadilkar VV, Padidela R.

J Pediatr. 2020 Jan;216:197-203. doi: 10.1016/j.jpeds.2019.09.028. Epub 2019 Nov 6.

PMID:
31704050
3.

Muscle and bone parameters in underprivileged Indian children and adolescents with T1DM.

Dongare-Bhor S, Lohiya N, Maheshwari A, Ekbote V, Chiplonkar S, Padidela R, Mughal Z, Khadilkar V, Khadilkar A.

Bone. 2020 Jan;130:115074. doi: 10.1016/j.bone.2019.115074. Epub 2019 Oct 15.

PMID:
31626994
4.

Central venous catheter-associated thrombosis in children with congenital hyperinsulinism

Yau D, Salomon-Estebanez M, Chinoy A, Grainger J, Craigie RJ, Padidela R, Skae M, Dunne MJ, Murray PG, Banerjee I.

Endocrinol Diabetes Metab Case Rep. 2019 Jul 9;2019(1). doi: 10.1530/EDM-19-0032.

5.

Severe hypokalaemia in diabetic ketoacidosis: a contributor to central pontine myelinolysis?

Chinoy A, Wright NB, Bone M, Padidela R.

Endocrinol Diabetes Metab Case Rep. 2019 May 30;2019(1). doi: 10.1530/EDM-19-0034.

6.

Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1.

Gopal-Kothandapani JS, Doshi AB, Smith K, Christian M, Mushtaq T, Banerjee I, Padidela R, Ramakrishnan R, Owen C, Cheetham T, Dimitri P.

J Pediatr Endocrinol Metab. 2019 Sep 25;32(9):959-967. doi: 10.1515/jpem-2018-0538.

PMID:
31301676
7.

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA.

Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16. Erratum in: Lancet. 2019 Jul 13;394(10193):120.

PMID:
31104833
8.

Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences.

Chinoy A, Mughal MZ, Padidela R.

Arch Dis Child Fetal Neonatal Ed. 2019 Sep;104(5):F560-F566. doi: 10.1136/archdischild-2018-316330. Epub 2019 May 11. Review.

PMID:
31079069
9.

Asfotase alfa treatment in perinatal and infantile hypophosphatasia: safe and sustained efficacy.

Padidela R.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):76-78. doi: 10.1016/S2213-8587(18)30321-8. Epub 2018 Dec 14. No abstract available.

PMID:
30558908
10.

Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With Histological Heterogeneity of Islet Cell Lesions.

Craigie RJ, Salomon-Estebanez M, Yau D, Han B, Mal W, Newbould M, Cheesman E, Bitetti S, Mohamed Z, Sajjan R, Padidela R, Skae M, Flanagan S, Ellard S, Cosgrove KE, Banerjee I, Dunne MJ.

Front Endocrinol (Lausanne). 2018 Oct 17;9:619. doi: 10.3389/fendo.2018.00619. eCollection 2018.

11.

Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations.

Daniel AB, Saraff V, Shaw NJ, Yates R, Mughal MZ, Padidela R.

Orphanet J Rare Dis. 2018 Aug 16;13(1):142. doi: 10.1186/s13023-018-0869-4.

12.

Growth, bone health & ambulatory status of boys with DMD treated with daily vs. intermittent oral glucocorticoid regimen.

Crabtree NJ, Adams JE, Padidela R, Shaw NJ, Högler W, Roper H, Hughes I, Daniel A, Mughal MZ.

Bone. 2018 Nov;116:181-186. doi: 10.1016/j.bone.2018.07.019. Epub 2018 Jul 25.

PMID:
30055340
13.

Duration of Casual Sunlight Exposure Necessary for Adequate Vitamin D Status in Indian Men.

Patwardhan VG, Mughal ZM, Chiplonkar SA, Webb AR, Kift R, Khadilkar VV, Padidela R, Khadilkar AV.

Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):249-255. doi: 10.4103/ijem.IJEM_473_17.

14.

Burosumab Therapy in Children with X-Linked Hypophosphatemia.

Carpenter TO, Whyte MP, Imel EA, Boot AM, Högler W, Linglart A, Padidela R, Van't Hoff W, Mao M, Chen CY, Skrinar A, Kakkis E, San Martin J, Portale AA.

N Engl J Med. 2018 May 24;378(21):1987-1998. doi: 10.1056/NEJMoa1714641.

15.

Retrospective review of Synacthen testing in infants.

Tan TSE, Manfredonia C, Kumar R, Jones J, O'Shea E, Padidela R, Skae M, Ehtisham S, Ivison F, Tetlow L, Clayton PE, Banerjee I, Patel L.

Arch Dis Child. 2018 Oct;103(10):984-986. doi: 10.1136/archdischild-2017-313819. Epub 2018 Jan 12.

PMID:
29330170
16.

Impact of dietary nutrient intake and physical activity on body composition and growth in Indian children.

Khadilkar AV, Chiplonkar SA, Kajale NA, Ekbote VH, Parathasarathi L, Padidela R, Khadilkar VV.

Pediatr Res. 2018 Apr;83(4):843-850. doi: 10.1038/pr.2017.322. Epub 2018 Jan 17.

PMID:
29278646
17.

P4HB recurrent missense mutation causing Cole-Carpenter syndrome.

Balasubramanian M, Padidela R, Pollitt RC, Bishop NJ, Mughal MZ, Offiah AC, Wagner BE, McCaughey J, Stephens DJ.

J Med Genet. 2018 Mar;55(3):158-165. doi: 10.1136/jmedgenet-2017-104899. Epub 2017 Dec 20.

18.

Impact of intercurrent illness on calcium homeostasis in children with hypoparathyroidism: a case series.

Chinoy A, Skae M, Babiker A, Kendall D, Mughal MZ, Padidela R.

Endocr Connect. 2017 Nov;6(8):589-594. doi: 10.1530/EC-17-0234.

19.

Prevalence of Metabolic Syndrome Markers among Women at 1-year Postpartum as per Prepregnancy Body Mass Index Status: A Longitudinal Study.

Kajale NA, Khadilkar V, Chiplonkar SA, Padidela R, Khadilkar AV.

Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):703-709. doi: 10.4103/ijem.IJEM_145_17.

20.

Response to Letter to the Editor: "The Effect of Whole Body Vibration Training on Bone and Muscle Function in Children With Osteogenesis Imperfecta".

Högler W, Bishop N, Nightingale P, Shaw N, Padidela R, Crabtree N.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4262-4263. doi: 10.1210/jc.2017-01682. No abstract available.

PMID:
28938474
21.

Atypical Forms of Congenital Hyperinsulinism in Infancy Are Associated With Mosaic Patterns of Immature Islet Cells.

Han B, Mohamed Z, Estebanez MS, Craigie RJ, Newbould M, Cheesman E, Padidela R, Skae M, Johnson M, Flanagan S, Ellard S, Cosgrove KE, Banerjee I, Dunne MJ.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3261-3267. doi: 10.1210/jc.2017-00158.

22.

Randomized Control Trial Assessing Impact of Increased Sunlight Exposure versus Vitamin D Supplementation on Lipid Profile in Indian Vitamin D Deficient Men.

Patwardhan VG, Mughal ZM, Padidela R, Chiplonkar SA, Khadilkar VV, Khadilkar AV.

Indian J Endocrinol Metab. 2017 May-Jun;21(3):393-398. doi: 10.4103/ijem.IJEM_9_17.

23.

Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI).

Salomon-Estebanez M, Mohamed Z, Michaelidou M, Collins H, Rigby L, Skae M, Padidela R, Rust S, Dunne M, Cosgrove K, Banerjee I, Nicholson J.

Orphanet J Rare Dis. 2017 May 22;12(1):96. doi: 10.1186/s13023-017-0648-7.

24.

The Effect of Whole Body Vibration Training on Bone and Muscle Function in Children With Osteogenesis Imperfecta.

Högler W, Scott J, Bishop N, Arundel P, Nightingale P, Mughal MZ, Padidela R, Shaw N, Crabtree N.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2734-2743. doi: 10.1210/jc.2017-00275.

25.

Interrelationship between serum 25-hydroxyvitamin D3 concentration and lipid profiles in premenopausal Indian women.

Patel PA, Patel PP, Mughal Z, Padidela R, Patel AD, Patwardhan V, Chiplonkar SA, Khadilkar V, Khadilkar A.

Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):96-101. doi: 10.4103/2230-8210.196014.

26.

Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.

Salomon-Estebanez M, Flanagan SE, Ellard S, Rigby L, Bowden L, Mohamed Z, Nicholson J, Skae M, Hall C, Craigie R, Padidela R, Murphy N, Randell T, Cosgrove KE, Dunne MJ, Banerjee I.

Orphanet J Rare Dis. 2016 Dec 1;11(1):163.

27.

mTOR Inhibitors for the Treatment of Severe Congenital Hyperinsulinism: Perspectives on Limited Therapeutic Success.

Szymanowski M, Estebanez MS, Padidela R, Han B, Mosinska K, Stevens A, Damaj L, Pihan-Le Bars F, Lascouts E, Reynaud R, Ferreira C, Bansept C, de Lonlay P, Saint-Martin C, Dunne MJ, Banerjee I, Arnoux JB.

J Clin Endocrinol Metab. 2016 Dec;101(12):4719-4729. Epub 2016 Oct 3.

PMID:
27691052
28.

Comprehensive Screening of Eight Known Causative Genes in Congenital Hypothyroidism With Gland-in-Situ.

Nicholas AK, Serra EG, Cangul H, Alyaarubi S, Ullah I, Schoenmakers E, Deeb A, Habeb AM, Almaghamsi M, Peters C, Nathwani N, Aycan Z, Saglam H, Bober E, Dattani M, Shenoy S, Murray PG, Babiker A, Willemsen R, Thankamony A, Lyons G, Irwin R, Padidela R, Tharian K, Davies JH, Puthi V, Park SM, Massoud AF, Gregory JW, Albanese A, Pease-Gevers E, Martin H, Brugger K, Maher ER, Chatterjee VK, Anderson CA, Schoenmakers N.

J Clin Endocrinol Metab. 2016 Dec;101(12):4521-4531. Epub 2016 Aug 15.

29.

Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease.

Han B, Newbould M, Batra G, Cheesman E, Craigie RJ, Mohamed Z, Rigby L, Padidela R, Skae M, Mironov A, Starborg T, Kadler KE, Cosgrove KE, Banerjee I, Dunne MJ.

Am J Clin Pathol. 2016 Jun;145(6):757-68. doi: 10.1093/ajcp/aqw075.

30.

Feeding Problems Are Persistent in Children with Severe Congenital Hyperinsulinism.

Banerjee I, Forsythe L, Skae M, Avatapalle HB, Rigby L, Bowden LE, Craigie R, Padidela R, Ehtisham S, Patel L, Cosgrove KE, Dunne MJ, Clayton PE.

Front Endocrinol (Lausanne). 2016 Feb 9;7:8. doi: 10.3389/fendo.2016.00008. eCollection 2016.

31.

Rapid assessment of dietary calcium intake.

Nordblad M, Graham F, Mughal MZ, Padidela R.

Arch Dis Child. 2016 Jul;101(7):634-6. doi: 10.1136/archdischild-2015-308905. Epub 2015 Dec 10.

PMID:
26662924
32.

Miscellaneous Bone Disorders.

Mughal MZ, Padidela R.

Endocr Dev. 2015;28:226-46. doi: 10.1159/000381048. Epub 2015 Jun 12. Review.

PMID:
26138845
33.

Increased plasma incretin concentrations identifies a subset of patients with persistent congenital hyperinsulinism without KATP channel gene defects.

Shi Y, Avatapalle HB, Skae MS, Padidela R, Newbould M, Rigby L, Flanagan SE, Ellard S, Rahier J, Clayton PE, Dunne MJ, Banerjee I, Cosgrove KE.

J Pediatr. 2015 Jan;166(1):191-4. doi: 10.1016/j.jpeds.2014.09.019. Epub 2014 Oct 23.

34.

Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPA(R.).

Skae M, Avatapalle HB, Banerjee I, Rigby L, Vail A, Foster P, Charalambous C, Bowden L, Padidela R, Patel L, Ehtisham S, Cosgrove KE, Dunne MJ, Clayton PE.

Front Endocrinol (Lausanne). 2014 Mar 12;5:31. doi: 10.3389/fendo.2014.00031. eCollection 2014.

35.

Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients.

Padidela R, Fiest M, Arya V, Smith VV, Ashworth M, Rampling D, Newbould M, Batra G, James J, Wright NB, Dunne MJ, Clayton PE, Banerjee I, Hussain K.

Eur J Endocrinol. 2014 Apr 10;170(5):741-7. doi: 10.1530/EJE-13-1008. Print 2014 May.

PMID:
24599222
36.

Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism.

Avatapalle HB, Banerjee I, Shah S, Pryce M, Nicholson J, Rigby L, Caine L, Didi M, Skae M, Ehtisham S, Patel L, Padidela R, Cosgrove KE, Dunne MJ, Clayton PE.

Front Endocrinol (Lausanne). 2013 May 20;4:60. doi: 10.3389/fendo.2013.00060. eCollection 2013.

37.

Can network biology unravel the aetiology of congenital hyperinsulinism?

Stevens A, Cosgrove KE, Padidela R, Skae MS, Clayton PE, Banerjee I, Dunne MJ.

Orphanet J Rare Dis. 2013 Feb 8;8:21. doi: 10.1186/1750-1172-8-21.

38.

Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism.

Banerjee I, Avatapalle B, Padidela R, Stevens A, Cosgrove KE, Clayton PE, Dunne MJ.

Clin Endocrinol (Oxf). 2013 Jun;78(6):803-13. doi: 10.1111/cen.12153. Review.

PMID:
23347463
39.

The association of cardiac ventricular hypertrophy with congenital hyperinsulinism.

Banerjee I, Avatapalle B, Petkar A, Skae M, Padidela R, Ehtisham S, Patel L, Rigby L, Flanagan S, Ellard S, Jones C, Ciotti G, Malaiya N, Clayton PE.

Eur J Endocrinol. 2012 Nov;167(5):619-24. doi: 10.1530/EJE-12-0632. Epub 2012 Aug 15.

PMID:
22894813
40.

Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism.

Avatapalle B, Padidela R, Randell T, Banerjee I.

BMJ Case Rep. 2012 Jul 30;2012. pii: bcr2012006271. doi: 10.1136/bcr-2012-006271.

41.

Echocardiography monitoring for diazoxide induced pericardial effusion.

Avatapalle B, Banerjee I, Malaiya N, Padidela R.

BMJ Case Rep. 2012 Jul 3;2012. pii: bcr0320126110. doi: 10.1136/bcr.03.2012.6110. No abstract available.

42.

Severe resistance to weight gain, lack of stored triglycerides in adipose tissue, hypoglycaemia, and increased energy expenditure: a novel disorder of energy homeostasis.

Padidela R, Bennett K, Nessa A, Wells J, Aufieri R, James C, Smith VV, Brain C, Eaton S, Hussain K.

Horm Res Paediatr. 2012;77(4):261-8. doi: 10.1159/000337248. Epub 2012 Apr 26.

PMID:
22538517
43.

Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.

Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J, Sykiotis GP, Gregory LC, Diaczok D, Tziaferi V, Elting MW, Padidela R, Plummer L, Martin C, Feng B, Zhang C, Zhou QY, Chen H, Mohammadi M, Quinton R, Sidis Y, Radovick S, Dattani MT, Pitteloud N.

J Clin Endocrinol Metab. 2012 Apr;97(4):E694-9. doi: 10.1210/jc.2011-2938. Epub 2012 Feb 8.

44.

The growth hormone receptor gene deleted for exon three (GHRd3) polymorphism is associated with birth and placental weight.

Padidela R, Bryan SM, Abu-Amero S, Hudson-Davies RE, Achermann JC, Moore GE, Hindmarsh PC.

Clin Endocrinol (Oxf). 2012 Feb;76(2):236-40. doi: 10.1111/j.1365-2265.2011.04207.x.

45.

Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans.

Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, Luan J, Montano S, Lu J, Castanet M, Clemons N, Groeneveld M, Castets P, Karbaschi M, Aitken S, Dixon A, Williams J, Campi I, Blount M, Burton H, Muntoni F, O'Donovan D, Dean A, Warren A, Brierley C, Baguley D, Guicheney P, Fitzgerald R, Coles A, Gaston H, Todd P, Holmgren A, Khanna KK, Cooke M, Semple R, Halsall D, Wareham N, Schwabe J, Grasso L, Beck-Peccoz P, Ogunko A, Dattani M, Gurnell M, Chatterjee K.

J Clin Invest. 2010 Dec;120(12):4220-35. doi: 10.1172/JCI43653. Epub 2010 Nov 15.

46.

Focal congenital hyperinsulinism in a patient with septo-optic dysplasia.

Padidela R, Kapoor RR, Moyo Y, Gilbert C, Flanagan SE, Ellard S, Hussain K.

Nat Rev Endocrinol. 2010 Nov;6(11):646-50. doi: 10.1038/nrendo.2010.153. Epub 2010 Sep 14.

PMID:
20842182
47.

Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia.

Padidela R, Hindmarsh PC.

Int J Pediatr Endocrinol. 2010;2010:656925. doi: 10.1155/2010/656925. Epub 2010 May 4.

48.

Abnormal growth in noonan syndrome: the challenge of optimal therapy.

Savage MO, Padidela R, Kirk JM, Malaquias AC, Jorge AA.

Pediatr Endocrinol Rev. 2009 Jun;6 Suppl 4:523-8. Review.

PMID:
19550387
49.

Mutation in the TBCE gene is associated with hypoparathyroidism-retardation-dysmorphism syndrome featuring pituitary hormone deficiencies and hypoplasia of the anterior pituitary and the corpus callosum.

Padidela R, Kelberman D, Press M, Al-Khawari M, Hindmarsh PC, Dattani MT.

J Clin Endocrinol Metab. 2009 Aug;94(8):2686-91. doi: 10.1210/jc.2008-2788. Epub 2009 Jun 2.

PMID:
19491227
50.

SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway.

Cliffe ST, Kramer JM, Hussain K, Robben JH, de Jong EK, de Brouwer AP, Nibbeling E, Kamsteeg EJ, Wong M, Prendiville J, James C, Padidela R, Becknell C, van Bokhoven H, Deen PM, Hennekam RC, Lindeman R, Schenck A, Roscioli T, Buckley MF.

Hum Mol Genet. 2009 Jun 15;18(12):2257-65. doi: 10.1093/hmg/ddp161. Epub 2009 Mar 31.

PMID:
19336477

Supplemental Content

Loading ...
Support Center